Compare Stocks → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison OTCMKTS:AOWDFOTCMKTS:BRRZYOTCMKTS:OPHRYOTCMKTS:OROCFOTCMKTS:OXBDF Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAOWDFAO World$2.05$2.05$1.99▼$3.27$938.42M-0.17900 shsN/ABRRZYTotal Brain$5.00$5.00$5.00▼$5.00$53.13M5.180 shsN/AOPHRYOPHIR ENERGY PL/ADR$1.48+5.7%$1.48$0.50▼$1.79$523.27M0.5116,436 shs2,000 shsOROCFAllkem$6.80+1.5%$6.80$5.34▼$11.66N/A1.6814,560 shs1,900 shsOXBDFOxford Biomedica$2.72$2.46$2.09▼$6.02$261.83M1.15195 shsN/AMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAOWDFAO World0.00%0.00%0.00%0.00%0.00%BRRZYTotal Brain0.00%0.00%0.00%0.00%0.00%OPHRYOPHIR ENERGY PL/ADR0.00%0.00%0.00%0.00%0.00%OROCFAllkem0.00%0.00%0.00%0.00%-11.23%OXBDFOxford Biomedica0.00%+4.02%+9.68%+15.99%-50.77%World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAOWDFAO WorldN/AN/AN/AN/AN/AN/AN/AN/ABRRZYTotal BrainN/AN/AN/AN/AN/AN/AN/AN/AOPHRYOPHIR ENERGY PL/ADRN/AN/AN/AN/AN/AN/AN/AN/AOROCFAllkemN/AN/AN/AN/AN/AN/AN/AN/AOXBDFOxford BiomedicaN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAOWDFAO WorldN/AN/AN/AN/ABRRZYTotal BrainN/AN/AN/AN/AOPHRYOPHIR ENERGY PL/ADRN/AN/AN/AN/AOROCFAllkem2.00HoldN/AN/AOXBDFOxford Biomedica2.25HoldN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAOWDFAO World$2.13B0.44N/AN/A$0.22 per share9.30BRRZYTotal Brain$2.60M20.43N/AN/A$1.67 per share2.99OPHRYOPHIR ENERGY PL/ADR$188.53M2.78N/AN/A$4.14 per share0.36OROCFAllkem$1.21BN/A$1.10 per share6.16$8.96 per shareN/AOXBDFOxford Biomedica$173.19M1.51N/AN/A$3.03 per share0.90Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAOWDFAO World-$41.52MN/A0.00204.54N/AN/AN/AN/AN/ABRRZYTotal Brain-$5.14MN/A0.00∞N/AN/AN/AN/AN/AOPHRYOPHIR ENERGY PL/ADR-$111.79MN/A0.0013.45N/AN/AN/AN/AN/AOROCFAllkem$441.71MN/A0.0042.50N/AN/AN/AN/AN/AOXBDFOxford Biomedica-$48.43MN/A0.00N/AN/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAOWDFAO WorldN/AN/AN/AN/AN/ABRRZYTotal BrainN/AN/AN/AN/AN/AOPHRYOPHIR ENERGY PL/ADRN/AN/AN/AN/AN/AOROCFAllkemN/AN/AN/AN/AN/AOXBDFOxford BiomedicaN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAOWDFAO WorldN/A0.760.50BRRZYTotal BrainN/AN/AN/AOPHRYOPHIR ENERGY PL/ADRN/AN/AN/AOROCFAllkem0.082.522.23OXBDFOxford BiomedicaN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipAOWDFAO WorldN/ABRRZYTotal BrainN/AOPHRYOPHIR ENERGY PL/ADRN/AOROCFAllkemN/AOXBDFOxford BiomedicaN/AInsider OwnershipCompanyInsider OwnershipAOWDFAO WorldN/ABRRZYTotal BrainN/AOPHRYOPHIR ENERGY PL/ADRN/AOROCFAllkemN/AOXBDFOxford BiomedicaN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAOWDFAO World4,442458.79 millionN/ANot OptionableBRRZYTotal BrainN/A10.63 millionN/ANot OptionableOPHRYOPHIR ENERGY PL/ADR386353.56 millionN/ANot OptionableOROCFAllkem1,350N/AN/ANot OptionableOXBDFOxford Biomedica89196.26 millionN/ANot OptionableOXBDF, BRRZY, OPHRY, AOWDF, and OROCF HeadlinesSourceHeadlineOxford BioMedica PLCbarrons.com - April 20 at 3:44 PMOxford Biomedica Insiders Placed Bullish Bets Worth UK£415.3kfinance.yahoo.com - March 30 at 10:23 AMOxford BioMedica sees highest patent filings and grants during December in Q4 2023pharmaceutical-technology.com - February 27 at 10:48 AMOxford BioMedica PLC (OXB)investing.com - January 23 at 11:53 PMOxford Biomedica is hosting a free webinar to share clients’ success stories in viral vector manufacturingfinance.yahoo.com - January 23 at 8:52 AMOxford Biomedica acquires ABL Europebioprocessintl.com - December 8 at 1:31 PMOxford BioMedica posts optimistic outlook on uptick in contract valueshareprices.com - December 7 at 6:54 PMOxford Biomedica strikes €15M deal to acquire French CDMO ABL Europefiercepharma.com - December 5 at 1:45 PMOxford Biomedica signs agreement to acquire ABL Europe from Institut Mérieuxpoandpo.com - December 5 at 8:45 AMOxford BioMedica PLC OXOAmorningstar.com - November 5 at 12:41 AMAnalysts Just Slashed Their Oxford Biomedica plc (LON:OXB) EPS Numbersfinance.yahoo.com - September 25 at 4:56 AMOxford BioMedica shares boom as manufacturer expands complex cancer therapiesmsn.com - September 21 at 1:16 PMOxford BioMedica shares up, in talks to buy ABL Europe but loss widenslse.co.uk - September 20 at 8:20 AMOxford Biomedica stock soars on rosy forecast, talks to buy ABL Europemsn.com - September 20 at 8:20 AMOxford BioMedica Shares Rise on Transformational Deal Talks, Revenue Growth Expectationmarketwatch.com - September 20 at 8:20 AMOxford Biomedica and Institut Mérieux enter into exclusive negotiations with respect to the proposed acquisition by Oxford Biomedica of ABL Europe from Institut Mérieux as part of pure-play CDMO transformationfinance.yahoo.com - September 20 at 8:20 AMKyverna Therapeutics and Oxford Biomedica Sign License and Supply Agreement for LentiVector® Platformfinance.yahoo.com - September 20 at 8:20 AMOxford 250 history: The second decadesunjournal.com - September 10 at 3:32 PMOxford Biomedica to host webinar showcasing the TetraVecta™ systemfinance.yahoo.com - September 7 at 8:04 AMOxford scientists find no evidence to suggest Facebook not good for wellbeingindependent.co.uk - August 23 at 2:53 AMLetchworth man jailed for Oxford BioMedica 'blackmail'readingchronicle.co.uk - July 11 at 6:17 PMOxford BioMedica company 'blackmailed' for £300k by analystoxfordmail.co.uk - July 11 at 1:17 PMOxford BioMedica company 'blackmailed' out of £300kthisisoxfordshire.co.uk - July 11 at 8:16 AMOxford Biomedica (LON:OXB) shareholders have endured a 50% loss from investing in the stock five years agofinance.yahoo.com - July 10 at 6:00 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsAO WorldOTCMKTS:AOWDFAO World plc, together with its subsidiaries, engages in the online retailing of domestic appliances the United Kingdom and Germany. It retails fridge freezers, cookers and washing machines, and audiovisual equipment, as well as computing, mobile, gaming, and smart home technology products. The company also provides logistics and transport services. In addition, it engages in the investment activities; and waste electrical and electronic equipment (WEEE) recycling activities. The company sells its products through its websites, marketplaces, and third-party websites. AO World plc was founded in 2000 and is headquartered in Bolton, the United Kingdom.Total BrainOTCMKTS:BRRZYTotal Brain Limited, together with its subsidiaries, develops and sells brain health products in the United States. It offers Total Brain, a neuroscience-based mental health and brain performance app. Total Brain Limited has a partnership with the Center for Adolescent Research and Education to address growing youth mental health crisis. The company was formerly known as Brain Resource Limited and changed its name to Total Brain Limited in December 2018. Total Brain Limited was founded in 2000 and is based in Surry Hills, Australia.OPHIR ENERGY PL/ADROTCMKTS:OPHRYOphir Energy plc engages in the exploration, development, and production of upstream oil and gas properties in Asia and Africa. The company develops offshore and deep-water oil and gas exploration assets. It has 1 billion barrel of oil equivalent of reserves and resources. Ophir Energy plc was founded in 2004 and is headquartered in London, the United Kingdom.AllkemOTCMKTS:OROCFAllkem Limited engages in the production and sale of lithium and boron in Argentina. Its flagship project is the Olaroz Lithium Facility located in Jujuy province in northern Argentina. Allkem Limited was incorporated in 2005 and is headquartered in Brisbane, Australia.Oxford BiomedicaOTCMKTS:OXBDFOxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, and adenoviral vectors. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.